Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Indian firm Panacea says aiming to make COVID-19 vaccine

FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with U.S.-based Refana Inc to make a potential vaccine for COVID-19.

The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges. (https://bit.ly/3dPPZQM)

Panacea's shares jumped 20% in morning trading on India's National Stock Exchange after the news.

(Reporting by Sachin Ravikumar; Editing by Shailesh Kuber)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.